Guide for patients & caregivers
Low-Grade Dysplasia on a Biopsy: What Does It Mean?
Low-grade dysplasia on a biopsy explained: what the term means in the gut, cervix or Barrett's, why it is not cancer, how surveillance works and what to ask.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What does low-grade dysplasia on a biopsy mean?
Low-grade dysplasia means a pathologist has seen cells that look mildly abnormal under the microscope. It is not cancer. Dysplasia describes changes that may, but often do not, progress, which is why doctors usually watch it with repeat checks or sometimes remove it.
This guide explains the term as it appears on biopsy reports from different parts of the body, especially the oesophagus (Barrett's oesophagus), the cervix and the bowel. It does not repeat the detailed guides on each condition; links to those are at the end. It cannot tell you what your own result means for you. Your care team, who know the full report and your history, can do that.
Symptoms that need sooner care
Dysplasia itself usually causes no symptoms. Cleveland Clinic notes that abnormal cells do not usually cause symptoms at first, which is why screening and surveillance matter. New or changing symptoms are still worth acting on, whatever the biopsy said.
For the gut, the NHS advises asking for an urgent GP appointment or contacting NHS 111 (or your local equivalent) if your poo is black or dark red, you have bloody diarrhoea, or you have been sick for more than 2 days. It advises calling 999 or going to A&E for non-stop bleeding from the bottom or a lot of blood or large clots when you poo. See a doctor soon for new problems swallowing, weight loss without trying, or heartburn most days for 3 weeks or more.
For the cervix, see a doctor about unusual vaginal bleeding, such as bleeding after sex. If you had a cervical biopsy, the NHS advises contacting a GP or 111 for heavy bleeding that is more than a heavy period, smelly discharge, or tummy pain that does not ease with painkillers.
Is low-grade dysplasia cancer?
No. Dysplasia refers to cells that look or act differently from normal cells. Cleveland Clinic stresses that dysplasia is not cancer and that it means cells may, not will, progress. It also notes that, in practice, dysplasia usually does not progress.
Doctors grade dysplasia by how abnormal the cells look. Low grade means the changes are milder. High-grade dysplasia is more likely to become cancer than low-grade dysplasia, so the grade on the report shapes how closely you are followed up. A finding of low-grade dysplasia is often a reason for closer checking, not a reason for alarm.
The word ‘dysplasia’ is also used for unrelated conditions present from birth, such as hip dysplasia. If your report comes from a biopsy of the lining of an organ, it refers to cell changes, not a developmental condition.
Low-grade dysplasia in Barrett's oesophagus
In Barrett's oesophagus, the lining of the food pipe changes to become more like the lining of the intestine, often after long-term reflux. NIDDK explains that before cancer develops, abnormal cells can appear in the Barrett's tissue, and doctors classify these as low grade or high grade. It also notes that most people with Barrett's oesophagus do not develop cancer.
Barrett's is usually checked with an upper endoscopy, during which biopsies are taken from several areas because the change does not affect all the tissue evenly. NIDDK describes repeat endoscopy on a set schedule as surveillance, and says your doctor may recommend repeating it more often if abnormal cells are found. Some people with dysplasia are offered endoscopic treatment; your gastroenterologist can explain whether that applies to you. Our guide on Barrett's oesophagus on endoscopy covers the condition and its surveillance in more detail.
Low-grade dysplasia of the cervix (CIN 1)
On a cervical biopsy, abnormal cells are usually described as cervical intraepithelial neoplasia (CIN). The NHS lists CIN 1 as low grade and says no immediate treatment is needed; you may be offered a follow-up smear test or colposcopy to check the cells. The US National Cancer Institute (NCI) adds that CIN 1 changes are mild and usually go away on their own.
On a smear (Pap) test rather than a biopsy, similar mild changes may be reported as a low-grade squamous intraepithelial lesion (LSIL). NCI describes these as low-grade changes usually caused by HPV infection, for which more testing is often arranged. Our CIN 1 guide explains monitoring after colposcopy step by step.
Low-grade dysplasia in a bowel polyp
Dysplasia can also appear on the pathology report for a polyp removed at colonoscopy, especially a type of polyp called an adenoma. Cleveland Clinic notes that dysplasia can occur in any part of the body where cancer may form, and that the grade reflects how abnormal the cells look. Many polyps are removed whole during the colonoscopy, so the report often describes tissue that has already been taken out.
Follow-up colonoscopy timing usually depends on the polyp type, size, number and whether it was fully removed, not on the word ‘dysplasia’ alone. Our tubular adenoma guide explains how polyp reports are used to plan follow-up.
What does surveillance involve?
Surveillance means repeating a test on a planned schedule to look for change. Depending on the organ, that may be a repeat endoscopy with biopsies, a repeat smear or colposcopy, or a later colonoscopy. Cleveland Clinic gives the example of low-grade cervical dysplasia being monitored, with removal considered only if the cells keep changing.
Surveillance only helps if it happens. Keep a note of when your next check is due and contact the service if you have not heard by then. If you take medicines for a related condition, such as reflux, do not start, stop or change them without speaking to the prescriber.
Questions to ask your clinician
Bring a copy of the full pathology report. These questions can help you understand the plan.
- Which organ and which area was the biopsy taken from?
- Is this definitely low-grade dysplasia, or is the report uncertain (for example ‘indefinite for dysplasia’)?
- Has another pathologist reviewed the slides, and is that usual for this type of result?
- Was the area removed completely, or only sampled?
- What surveillance do you recommend, and when is my next check?
- Is treatment to remove or destroy the area an option for me, and what are its pros and cons?
- Which new symptoms should make me get in touch before the next appointment?
How comparing similar cases on SameCase can help
On SameCase, patients and verified doctors share de-identified cases. Reading how others with a similar biopsy result worked through surveillance, and which questions they found useful, can help you prepare for your own appointment. We cannot interpret your report or tell you what your result means, and other people's paths may not match yours. Your own care team remains the place to make decisions.
Sources and further reading
- Cleveland Clinic: Dysplasia (medically reviewed February 2026)
- NIDDK: Definition and facts for Barrett's esophagus
- NIDDK: Diagnosis of Barrett's esophagus and surveillance (reviewed August 2024)
- NHS: Colposcopy, biopsy results and CIN grades (reviewed September 2026)
- National Cancer Institute: Understanding abnormal HPV and Pap test results
- NHS: Symptoms of oesophageal cancer and when to get urgent advice
- NHS: Symptoms of bowel cancer and when to get urgent help (reviewed September 2026)
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.